• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌前病变与医学治疗

Precancerous lesions of the endometrium and medical treatment.

作者信息

Taddei G L, Bargelli G, Scarselli B, Moncini D, Scarselli G

机构信息

Department of Pathology, University of Florence, Italy.

出版信息

Eur J Contracept Reprod Health Care. 1997 Dec;2(4):239-41. doi: 10.3109/13625189709165300.

DOI:10.3109/13625189709165300
PMID:9678079
Abstract

Endometrial hyperplasias, which occur in the premenopausal age and are often induced by anovulatory cycles, are kept under control by progestin therapy. The good results with natural and synthetic progestins suggest that this treatment can be used both in premenopause and postmenopause hyperplasia. The progestin effect on the endometrium appears through a marked pseudodecidual reaction of the stroma and functional atrophy of the glands. These events are reported in the literature as inactive or suppressed endometrium and there is no physiological equivalent.

摘要

子宫内膜增生发生在绝经前年龄,通常由无排卵周期引起,通过孕激素治疗可得到控制。天然和合成孕激素的良好治疗效果表明,这种治疗方法可用于绝经前和绝经后增生。孕激素对子宫内膜的作用表现为基质明显的假蜕膜反应和腺体的功能萎缩。文献中将这些情况报道为无活性或受抑制的子宫内膜,且不存在生理上的对应情况。

相似文献

1
Precancerous lesions of the endometrium and medical treatment.子宫内膜癌前病变与医学治疗
Eur J Contracept Reprod Health Care. 1997 Dec;2(4):239-41. doi: 10.3109/13625189709165300.
2
Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.是否应该评估孕激素和雌激素受体以预测子宫内膜增生和癌症保守治疗的反应?系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2019 Aug;98(8):976-987. doi: 10.1111/aogs.13586. Epub 2019 Mar 28.
3
Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.孕激素治疗的绝经前妇女中,复杂性非典型增生或 1 级子宫内膜腺癌消退的预测因素。
Gynecol Oncol. 2012 Mar;124(3):542-8. doi: 10.1016/j.ygyno.2011.11.004. Epub 2011 Nov 10.
4
Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.人类子宫内膜增生(子宫内膜癌的前驱病变)中孕激素抵抗演变所涉及的机制。
Gynecol Oncol. 2003 Feb;88(2):108-17. doi: 10.1016/s0090-8258(02)00008-2.
5
Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.用孕激素治疗的子宫内膜增生和高分化癌的组织学改变。
Am J Surg Pathol. 2007 Jul;31(7):988-98. doi: 10.1097/PAS.0b013e31802d68ce.
6
[Application of endometrial sampling device during the follow-up visit for the conservative treatment of endometrial cancer].
Zhonghua Fu Chan Ke Za Zhi. 2013 Dec;48(12):896-8.
7
Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.双特异性磷酸酶6可预测孕激素治疗非典型子宫内膜增生的敏感性。
Gynecol Oncol. 2015 Mar;136(3):549-53. doi: 10.1016/j.ygyno.2014.11.008. Epub 2014 Nov 14.
8
Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma.子宫内膜增生和早期腺癌的全身和局部激素治疗。
Obstet Gynecol. 2013 Jun;121(6):1172-1180. doi: 10.1097/AOG.0b013e31828d6186.
9
Atypical endometrial hyperplasia in an 18-year-old woman.
Arch Gynecol Obstet. 2003 Feb;267(4):252-5. doi: 10.1007/s00404-002-0433-1. Epub 2002 Oct 15.
10
Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.左炔诺孕酮宫内节育系统治疗复杂性子宫内膜增生的效果。
Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):176-9. doi: 10.1016/j.ejogrb.2011.06.025. Epub 2011 Jul 7.